Israel has vaccinated just over 20% of its population leading the world in shots in arms as a percentage of population. Their over 65 cohort has reached a 40% level. The big question that everyone wants to know, "when will we start to see a reduction in deaths and new infections as vaccines are rolled out? The Israelis have studied this. The answer is that at the current level of vaccinations, new infections are dropping by about 1/3 - less than had been hoped for but still encouraging
For the study’s first 12 days, positive test rates remained identical between groups. On the 13th, the vaccinated group’s rate fell slightly. Then, on day 14, it dropped by a third. There has been some disappointment that this drop was not greater, but the vaccine in question, the Pfizer-BioNTech offering, is intended to be given in two doses, so the picture will not be clear until the second doses have been administered, and results from younger people have been included, too.
The early effect on hospital admissions of Israel’s mass vaccination campaign has been trickier to measure, because of two confounding variables: the country’s national lockdown, which tends to reduce the rate regardless of the effect of vaccines, and the spread of b.1.1.7, a variant of the virus first found in Britain, which is a lot more contagious and so tends to push the rate up.
A sign that vaccination is starting to give Israeli hospitals some breathing space emerged a fortnight after January 2nd, the day when the proportion of those over 60 who had been vaccinated reached 40%. The number critically ill with covid-19 in that age group grew by about 30% in the week before January 2nd, and also in the following week—but by just 7% in the week after that.
It's something even though, out of the gate it seems, vaccines are not going to be the be-all-end all. Scientist new this. The public has expectations for the vaccines that are probably unrealistic and should cause people to continue to act responsibly.
For the study’s first 12 days, positive test rates remained identical between groups. On the 13th, the vaccinated group’s rate fell slightly. Then, on day 14, it dropped by a third. There has been some disappointment that this drop was not greater, but the vaccine in question, the Pfizer-BioNTech offering, is intended to be given in two doses, so the picture will not be clear until the second doses have been administered, and results from younger people have been included, too.
The early effect on hospital admissions of Israel’s mass vaccination campaign has been trickier to measure, because of two confounding variables: the country’s national lockdown, which tends to reduce the rate regardless of the effect of vaccines, and the spread of b.1.1.7, a variant of the virus first found in Britain, which is a lot more contagious and so tends to push the rate up.
A sign that vaccination is starting to give Israeli hospitals some breathing space emerged a fortnight after January 2nd, the day when the proportion of those over 60 who had been vaccinated reached 40%. The number critically ill with covid-19 in that age group grew by about 30% in the week before January 2nd, and also in the following week—but by just 7% in the week after that.
It's something even though, out of the gate it seems, vaccines are not going to be the be-all-end all. Scientist new this. The public has expectations for the vaccines that are probably unrealistic and should cause people to continue to act responsibly.
Comment